Eryzyme

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEryzyme
Drug Alias NameCystathionine Beta Synthase (ERYtech)Methionine Gamma-Lyase (ERYtech)
ClassificationBiologics > Protein drugs > EnzymeCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionLyases stimulantsCystathionine beta-synthase stimulants
TargetsCystathionine beta-synthaseLyases
Therapy Area/IndicationsHomocystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhaxiam Therapeutics SA
Active IndicationsN/A
Inactive IndicationsHomocystinuria

Other Information

ATC CodeN/A
Related LinksN/A